Cystic Fibrosis

Latest News

FDA approves brensocatib to treat adolescents with non-cystic fibrosis bronchiectasis | Image credit: Contemporary Pediatrics
August 12th 2025
FDA approves brensocatib to treat adolescents with non–cystic fibrosis bronchiectasis

Brensocatib was granted FDA priority review in February 2025 for the small molecule, oral, reversible inhibitor.

doctor checking on patient with stethoscope
February 17th 2020

How cystic fibrosis can manifest in the gastrointestinal system

February 2020 cover image for Contemporary Pediatrics
February 13th 2020

Gastrointestinal manifestations of cystic fibrosis: A primer for pediatricians

collection of pharmaceuticals
February 10th 2020

Triple combination therapy for cystic fibrosis is here!

CME Content

View More
Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?
In-Person + Virtual Event

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

January 23, 2026

View more
Burst CME: Targeted Therapy for Optimal Psoriasis Management
Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

View more
Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management
Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

View more
Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update
Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

View more